New CEO heads up Bibby Scientific
Bibby Scientific makes a major appointment, announcing Dr James Heffernan as the new Chief Executive Officer from 17 May.
Bibby Scientific.
James Heffernan holds a BSc in Chemistry, together with a PhD in Organic Chemistry, and brings 20 years’ experience in building successful and profitable businesses in the drug discovery, life science and biotechnology sectors. Most recently he was Group Managing Director of Biochrom Ltd which is a subsidiary of Harvard Biosciences, a US publicly traded company. Previously he spent several years as CEO of Nextgen Ltd; three years as VP Biotechnology with Sigma-Aldrich, the speciality chemicals and reagent supplier, and ten years in various executive positions at Promega, a leading supplier of advanced molecular biology research systems and reagents.
Most read news
Topics
Organizations
Other news from the department people
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.